156 related articles for article (PubMed ID: 33393677)
21. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
22. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
[TBL] [Abstract][Full Text] [Related]
23. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
[TBL] [Abstract][Full Text] [Related]
24. Proton Pump Inhibitor Use, H
Paik JM; Rosen HN; Gordon CM; Curhan GC
Calcif Tissue Int; 2018 Oct; 103(4):380-387. PubMed ID: 29754277
[TBL] [Abstract][Full Text] [Related]
25. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
[TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitor use and cancer mortality.
Tvingsholm SA; Dehlendorff C; Østerlind K; Friis S; Jäättelä M
Int J Cancer; 2018 Sep; 143(6):1315-1326. PubMed ID: 29658114
[TBL] [Abstract][Full Text] [Related]
27. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
[TBL] [Abstract][Full Text] [Related]
28. Effect of Gastric Acid Suppressants on Response to a Physical Activity Intervention and Major Mobility Disability in Older Adults: Results from the Lifestyle Interventions for Elders (LIFE) Study.
Squires PJ; Pahor M; Manini TM; Brown JD
Pharmacotherapy; 2019 Aug; 39(8):816-826. PubMed ID: 31230397
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
[TBL] [Abstract][Full Text] [Related]
30. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
[TBL] [Abstract][Full Text] [Related]
31. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
32. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
33. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
34. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
[TBL] [Abstract][Full Text] [Related]
35. Use of histamine H
Adelborg K; Sundbøll J; Schmidt M; Bøtker HE; Weiss NS; Pedersen L; Sørensen HT
Clin Epidemiol; 2018; 10():521-530. PubMed ID: 29765253
[TBL] [Abstract][Full Text] [Related]
36. Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study.
Murofushi T; Yagi T; Tsuji D; Furushima D; Fujikura T; Itoh K; Kawakami J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4927-4938. PubMed ID: 38170305
[TBL] [Abstract][Full Text] [Related]
37. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.
Li CM; Zhernakova A; Engstrand L; Wijmenga C; Brusselaers N
Aliment Pharmacol Ther; 2020 Feb; 51(4):410-420. PubMed ID: 31909512
[TBL] [Abstract][Full Text] [Related]
38. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
[TBL] [Abstract][Full Text] [Related]
40. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]